NH Investment & Securities Signs IPO Underwriting Agreement with Ulike Korea

[Asia Economy Reporter Hwang Yoon-joo] NH Investment & Securities announced on the 19th that it has signed a lead underwriting agreement for Ulike Korea (Initial Public Offering·IPO), a leading digital livestock company.

Ulike Korea is a specialized livestock healthcare service company. It currently operates a live care platform that researches livestock diseases and infectious diseases based on accumulated biometric data of livestock diseases. Unlike the existing tag method attached to the ears and legs of livestock, Live Care has a differentiated and unique technology with the orally administered bio capsule method, which was successfully developed for the first time in Korea.

The bio capsule settles in the cow's rumen, enabling accurate biometric data collection of cattle 24 hours a day, 365 days a year without being affected by external environments. As of March 2022, it has accumulated over 1 billion biometric data records.

Live Care analyzes the collected real-time biometric data with AI to detect cattle diseases early and accurately predict estrus and calving periods. Through its proprietary app, it provides optimal feeding management data to livestock farms not only in Korea but also globally in Japan, North America, and Latin America, contributing to improved farm productivity.

An NH Investment & Securities official stated, "Ulike Korea significantly contributes to reducing carbon emissions, a global issue, by enhancing livestock productivity through Live Care," adding, "It is a promising company in sustainable digital livestock applying a low-carbon livestock management system beyond smart livestock, and we expect a successful listing on the KOSDAQ market."

This content was produced with the assistance of AI translation services.